Better Bet on COVID Pills: Merck or Pfizer?
9/10 12:00
Until now, Pfizer (NYSE: PFE) has reigned in the coronavirus space. The big pharma company is the leading seller of coronavirus vaccines and expects its vaccine to generate more than $33 billion in revenue this year. At the same time, Pfizer is testing a coronavirus treatment can...